Shanghai Henlius Biotech's (HKG:2696) shares were included in Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect, effective Monday.
The stock connect programs are a collaboration between the Hong Kong, Shanghai and Shenzhen stock exchanges, enabling international and mainland Chinese investors to trade securities in each other's markets.
The biotech firm said its inclusion in the cross-border trading links would expand its shareholder base and boost the liquidity of its shares, Henlius said in a Monday disclosure.
Shares of Henlius fell over 3% in Monday's afternoon trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments